Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

CCL2 binding is CCR2 independent in primary adult human astrocytes.

Fouillet A, Mawson J, Suliman O, Sharrack B, Romero IA, Woodroofe MN.

Brain Res. 2012 Feb 9;1437:115-26. doi: 10.1016/j.brainres.2011.11.049.

PMID:
22226505
2.

Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.

Bose S, Cho J.

Arch Pharm Res. 2013 Sep;36(9):1039-50. doi: 10.1007/s12272-013-0161-z. Review.

PMID:
23771498
3.

The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).

Mahad DJ, Ransohoff RM.

Semin Immunol. 2003 Feb;15(1):23-32. Review.

PMID:
12495638
4.

Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Semple BD, Kossmann T, Morganti-Kossmann MC.

J Cereb Blood Flow Metab. 2010 Mar;30(3):459-73. doi: 10.1038/jcbfm.2009.240. Review.

5.

Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments.

Kang YS, Cha JJ, Hyun YY, Cha DR.

Expert Opin Investig Drugs. 2011 Jun;20(6):745-56. doi: 10.1517/13543784.2011.575359. Review.

PMID:
21466412
6.

CCL2-CCR2 Signaling in Disease Pathogenesis.

O'Connor T, Borsig L, Heikenwalder M.

Endocr Metab Immune Disord Drug Targets. 2015;15(2):105-18. Review.

PMID:
25772168
7.

Chemokine signaling and the management of neuropathic pain.

White FA, Feldman P, Miller RJ.

Mol Interv. 2009 Aug;9(4):188-95. doi: 10.1124/mi.9.4.7. Review.

8.

Review: Structure-function and biological properties of the atypical chemokine receptor D6.

Cancellieri C, Caronni N, Vacchini A, Savino B, Borroni EM, Locati M, Bonecchi R.

Mol Immunol. 2013 Aug;55(1):87-93. doi: 10.1016/j.molimm.2012.08.003. Review.

PMID:
22939232
9.

Epilepsy, Seizures, and Inflammation: Role of the C-C Motif Ligand 2 Chemokine.

Bozzi Y, Caleo M.

DNA Cell Biol. 2016 Jun;35(6):257-60. doi: 10.1089/dna.2016.3345. Review.

PMID:
27167681
10.

Regulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6.

Graham GJ, Locati M.

J Pathol. 2013 Jan;229(2):168-75. doi: 10.1002/path.4123. Review.

PMID:
23125030
11.

[Progress on Hypoxic-ischemic Brain Damage Associated with CCR2 and CCL2].

Luo YJ, Li RB, Ma SY, Lü MY.

Fa Yi Xue Za Zhi. 2016 Feb;32(1):54-7. Review. Chinese.

PMID:
27295859
12.

Role of CCR2 in inflammatory conditions of the central nervous system.

Chu HX, Arumugam TV, Gelderblom M, Magnus T, Drummond GR, Sobey CG.

J Cereb Blood Flow Metab. 2014 Sep;34(9):1425-9. doi: 10.1038/jcbfm.2014.120. Review.

13.

Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.

Gyoneva S, Ransohoff RM.

Trends Pharmacol Sci. 2015 Jul;36(7):471-80. doi: 10.1016/j.tips.2015.04.003. Review.

14.

The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?

Covino DA, Sabbatucci M, Fantuzzi L.

Curr Drug Targets. 2016;17(1):76-110. Review.

PMID:
26687605
15.

Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.

Zhang J, Patel L, Pienta KJ.

Prog Mol Biol Transl Sci. 2010;95:31-53. doi: 10.1016/B978-0-12-385071-3.00003-4. Review.

16.

[The role of CC-chemokine ligand 2 in the development of psychic dependence on methamphetamine].

Saika F, Kiguchi N, Kishioka S.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2015 Oct;50(5):189-95. Review. Japanese.

PMID:
26946780
17.

Targeting the CCL2-CCR2 signaling axis in cancer metastasis.

Lim SY, Yuzhalin AE, Gordon-Weeks AN, Muschel RJ.

Oncotarget. 2016 May 10;7(19):28697-710. doi: 10.18632/oncotarget.7376. Review.

18.

DARC and D6: silent partners in chemokine regulation?

Hansell CA, Hurson CE, Nibbs RJ.

Immunol Cell Biol. 2011 Feb;89(2):197-206. doi: 10.1038/icb.2010.147. Review.

19.

Mechanisms of Regulation of the Chemokine-Receptor Network.

Stone MJ, Hayward JA, Huang C, E Huma Z, Sanchez J.

Int J Mol Sci. 2017 Feb 7;18(2). pii: E342. doi: 10.3390/ijms18020342. Review.

20.

D6/ACKR2.

Graham GJ.

Front Immunol. 2015 Jun 5;6:280. doi: 10.3389/fimmu.2015.00280. Review. No abstract available.

Items per page

Supplemental Content

Support Center